Nitinol Medical Components Market Global Report 2026

The nitinol medical components market size has grown rapidly in recent years. It will grow from $1.41 billion in 2025 to $1.55 billion in 2026 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to the increasing adoption of minimally invasive surgeries, rising demand for cardiovascular intervention devices, growing use of Nitinol in endovascular stents, increasing demand for orthodontic treatment devices, and expanding utilization of shape memory alloys in medical applications.

The nitinol medical components market size is expected to see rapid growth in the next few years. It will grow to $2.28 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to increasing demand for advanced implantable medical devices, rising adoption of minimally invasive treatment techniques, growing demand for complex Nitinol medical components, increasing need for smaller and more flexible medical devices, and expanding use of Nitinol across emerging therapeutic applications. Major trends in the forecast period include increasing adoption of minimally invasive medical procedures, rising demand for shape-memory medical components, growing use of superelastic materials in implantable devices, increasing demand for miniaturized medical components, and rising focus on biocompatible and durable medical device materials.

The increasing demand for minimally invasive surgical procedures is expected to propel the growth of the nitinol medical components market going forward. Minimally invasive surgical procedures are medical techniques that use specialized instruments and small access points to diagnose or treat medical conditions while minimizing tissue damage, recovery time, and patient discomfort compared with conventional open surgery. The demand for minimally invasive procedures is increasing due to the growing preference of healthcare providers and patients for treatments that improve clinical outcomes, reduce surgical trauma, and shorten hospitalization and recovery periods. Nitinol medical components support these procedures by enabling the development of compact, flexible, self-expanding, and highly maneuverable medical devices that can be delivered through small catheters and accurately deployed at treatment sites. For instance, in January 2026, according to Intuitive Surgical, Inc., a US-based medical technology company specializing in robotic-assisted minimally invasive surgery, more than 3.1 million procedures were performed using its da Vinci surgical systems in 2025, representing approximately 18% growth compared with 2024. Therefore, the increasing adoption of minimally invasive surgical procedures is driving the growth of the nitinol medical components market.

Major companies operating in the nitinol medical component market are concentrating on developing advanced products, such as Nitinol wire and other precision material solutions, to address the growing demand for components used in minimally invasive and implantable medical devices. Nitinol wire is utilized to manufacture and reinforce medical components because of its superelasticity, shape-memory characteristics, flexibility, fatigue resistance, and ability to tolerate repeated deformation. For instance, in February 2026, Ulbrich, a US-based specialty metal manufacturer, highlighted its ultra-fine Nitinol wire for medical applications, including catheter reinforcement, coiling, braided stents, and retrieval baskets. The company also provides customized Nitinol round wire for medical braid products and implantable medical devices, including braided catheters, vascular catheters, guide wires, and implants, demonstrating the direct use of Nitinol materials within the medical component manufacturing supply chain.

In February 2025, Arterex LLC, a US-based medical device contract manufacturing company providing engineering, development, and manufacturing solutions for minimally invasive medical devices, acquired Adroit USA Inc. for an undisclosed amount. Through this acquisition, Arterex aimed to expand its global medical device manufacturing capabilities by incorporating vertically integrated precision manufacturing expertise, including nitinol component production, advanced machining, and complete device assembly capabilities, thereby enhancing its ability to support complex minimally invasive medical device applications. Adroit USA Inc. is a US-based medical device contract manufacturer that provides precision injection-molded plastic components, stainless steel and nitinol components, and fully assembled and packaged medical devices for healthcare technology companies.

Major companies operating in the nitinol medical components market are Integer Holdings Corporation, Kyocera Corporation, Mitsubishi Materials Corporation, Alleima AB, Furukawa Electric Co. Ltd., Carpenter Technology Corporation, ATI Inc., SAES Getters S.p.A., Resonetics, Fort Wayne Metals, Confluent Medical Technologies, ADMEDES GmbH, MeKo MedTech, EUROFLEX GmbH, Custom Wire Technologies Inc., California Fine Wire Company, Tokusen Kogyo Co. Ltd., Nippon Seisen Co. Ltd., Lighteum Medical.

North America was the dominating region in the nitinol medical components market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the nitinol medical components market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the nitinol medical components market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.